Experts seek painkiller ban

Last updated 05:00 14/02/2013

Relevant offers

Health

Queenstown eyed as 'medical mecca' Executive shuffle at Waikato DHB Rare illness spurs teen to start fundraiser Move to add folic acid to bread goes backward GP's melanoma miss criticised Surgical staff failed woman during C-section NZ gets air ambulance jet Former All Black becomes dementia champion Cancer-hit mum remains grateful ACC dispute dogs injured man

A popular painkiller should be banned worldwide because it raises the risk of heart attack and stroke by almost half, British academics say.

Risks from diclofenac, widely sold as Voltaren, were highest in those who used it regularly, and safer options were available, they said.

Medsafe in New Zealand said it would consider the research, but noted previous reviews had shown its benefits outweighed potential risks.

Diclofenac is a non-steroidal anti-inflammatory drug often prescribed after surgery or to combat arthritic pain when other painkillers are not strong enough.

It has been available in New Zealand for more than 20 years. I

t is subsidised by state drug-buying agency Pharmac, with 375,000 people being prescribed it in the year ending November 2012. That figure does not include those who buy it over the counter.

Ad Feedback

- The Dominion Post

Special offers
Opinion poll

Should fluoride in water be the responsibility of central government?

Yes

No

Vote Result

Featured Promotions

Sponsored Content